Form D · Pharmaceuticals

BIOMIMETIX PHARMACEUTICAL, INC.

Greenwood Village, CO · CIK 0001526474

Offering snapshot reported May 16, 2012 · SEC filing

Reported sold
$3.3M
Offering amount: $3.3M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 15, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.65M$3.3MJul 27, 2011: $2,000,000.00Jul 27, 2011Sep 28, 2011: $2,800,000.00Sep 28, 2011May 16, 2012: $3,300,000.00May 16, 2012

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,800,000 → $3,300,000
  • Reported investors2 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 16, 2012Amendment$3,300,000$500,000vs Sep 28, 20113SEC filing
Sep 28, 2011Amendment$2,800,000$800,000vs Jul 27, 20112SEC filing
Jul 27, 2011Initial$2,000,000No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
05
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-163503

Source: Form D, filed May 16, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Crapo Director, Executive
Robert Ogden Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
5350 S. Roslyn Street Suite 430
Greenwood Village, CO, 80111